Aino Health’s rights issue of approximately SEK 15.9 million was heavily oversubscribed. Approximately 88 per cent of the rights issue was allocated to subscribers who subscribed for shares with subscription rights and 12 per cent to those who subscribed for shares without subscription rights.
Augment acted as project leader to Aino Health in connection with the transaction.